Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 66.05
+0.30 (0.46%)
Jul 24, 2026, 5:35 PM CET
Redcare Pharmacy NV Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 92.6 | 92.4 | 96.9 | 84.16 | 66.78 | 247.41 |
Short-Term Investments | 42.4 | 111.1 | 80.7 | 127.06 | 117.56 | 36.42 |
Cash & Short-Term Investments | 135 | 203.5 | 177.6 | 211.22 | 184.33 | 283.83 |
Cash Growth | -26.96% | 14.58% | -15.92% | 14.59% | -35.05% | 121.30% |
Accounts Receivable | 156.4 | 129.5 | 109.8 | 103.13 | 30 | 52.31 |
Inventory | 214.8 | 214 | 153.8 | 135.79 | 99.71 | 96.62 |
Other Current Assets | 73.1 | 72.4 | 58.8 | 49.38 | 29.87 | - |
Total Current Assets | 579.3 | 619.4 | 500 | 499.52 | 343.92 | 432.76 |
Net Property, Plant & Equipment | 198.6 | 190.7 | 82.6 | 86.91 | 85.44 | 78.26 |
Other Intangible Assets | 389.9 | 393.5 | 411.3 | 428.11 | 289.01 | 257.48 |
Long-Term Investments | 1.5 | 1.5 | 1.4 | 1.31 | 1.27 | 1.47 |
Other Long-Term Assets | 9.2 | 9.2 | 8 | 5.75 | 9.85 | 13.11 |
Total Assets | 1,178 | 1,214 | 1,003 | 1,022 | 729.47 | 783.08 |
Accounts Payable | 278.7 | 253 | 184 | 157.59 | 72.88 | 80.52 |
Short-Term Debt | - | - | - | - | - | 0.04 |
Current Portion of Long-Term Debt | 23 | 86.3 | 9.7 | 8.77 | 7.55 | 6.37 |
Other Current Liabilities | 73.5 | 60.7 | 56 | 57.36 | 38.88 | 37.16 |
Total Current Liabilities | 375.1 | 400 | 249.7 | 223.72 | 119.31 | 124.09 |
Long-Term Debt | 331.8 | 330.3 | 237.6 | 236.07 | 247.65 | 230.03 |
Other Long-Term Liabilities | 3.2 | 4.8 | 6 | 9.77 | 7.89 | 13.55 |
Total Long-Term Liabilities | 335 | 335.1 | 243.6 | 245.84 | 255.54 | 243.58 |
Total Liabilities | 710.1 | 735.1 | 493.3 | 469.56 | 374.84 | 367.67 |
Additional Paid-in Capital | 755.9 | 755.9 | 755.3 | 733.42 | 571.06 | 566.9 |
Retained Earnings | -305.7 | -296.7 | -271.3 | -211.23 | -216.43 | -151.49 |
Total Common Shareholders' Equity | 450.2 | 459.2 | 484 | 522.19 | 354.63 | 415.41 |
Minority Interest | 18.1 | 20 | 26 | 29.84 | 0 | - |
Shareholders' Equity | 468.2 | 479.2 | 510 | 552.03 | 354.63 | 415.41 |
Total Liabilities & Equity | 1,178 | 1,214 | 1,003 | 1,022 | 729.47 | 783.08 |
Total Debt | 354.8 | 416.6 | 247.3 | 244.84 | 255.2 | 236.43 |
Net Cash (Debt) | -219.8 | -213.1 | -69.7 | -33.62 | -70.86 | 47.39 |
Net Cash Growth | - | - | - | - | - | -47.35% |
Net Cash Per Share | -10.76 | -10.60 | -3.48 | -1.75 | -3.94 | 2.65 |
Book Value | 450.2 | 459.2 | 484 | 522.19 | 354.63 | 415.41 |
Book Value Per Share | 22.05 | 22.84 | 24.13 | 27.14 | 19.72 | 23.23 |
Tangible Book Value | 60.3 | 65.7 | 72.7 | 94.09 | 65.63 | 157.94 |
Tangible Book Value Per Share | 2.95 | 3.27 | 3.63 | 4.89 | 3.65 | 8.83 |